Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
journalStr:"Multiple sclerosis and related disorders"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Immunologic+Factors%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22Multiple+sclerosis+and+related+disorders%22
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Immunologic+Factors%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22Multiple+sclerosis+and+related+disorders%22
Search /vufind/Search2/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Immunologic+Factors%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22Multiple+sclerosis+and+related+disorders%22
PubPharm (298)
1
Ocrelizumab in highly disabled progressive multiple sclerosis patients
enthalten in:
Multiple sclerosis and related disorders
| 2024
von
Houtchens, M.
|
Howard, D.
Wird geladen...
2
Neutropenia following immune-depletion, notably CD20 targeting, therapies in multiple sclerosis
enthalten in:
Multiple sclerosis and related disorders
| 2024
von
Baker, D.
|
Kang, A.
|
Giovannoni, G.
| +1
Wird geladen...
3
Fingolimod : Assay analysis of US generic capsule products reveals variation in fingolimod content beyond the recommended acceptance criteria
enthalten in:
Multiple sclerosis and related disorders
| 2023
von
Wainwright, C.
|
Fuller, S.
|
Dickinson, V.
| +1
Wird geladen...
4
Lessons learned after 20 years of real-world experience with natalizumab
enthalten in:
Multiple sclerosis and related disorders
| 2023
von
Khatri, B.
|
Olapo, T.
|
Beals, S.
| +4
Wird geladen...
5
Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model
enthalten in:
Multiple sclerosis and related disorders
| 2023
von
Corsten, C.
|
Huygens, S.
|
Versteegh, M.
| +3
Wird geladen...
6
Real world study of ocrelizumab in multiple sclerosis : Kuwait experience
enthalten in:
Multiple sclerosis and related disorders
| 2023
von
Alroughani, R.
|
AlMojel, M.
|
Al-Hashel, J.
| +1
Wird geladen...
7
"No association between disease modifying treatment and fatigue in multiple sclerosis"
enthalten in:
Multiple sclerosis and related disorders
| 2023
von
Broch, L.
|
Flemmen, H.
|
Simonsen, C.
| +4
Wird geladen...
8
Initial clinical and radiological features of patients with multiple sclerosis in Oman
enthalten in:
Multiple sclerosis and related disorders
| 2023
von
Al-Abri, S.
|
Al-Asmi, A.
|
Jose, S.
| +1
Wird geladen...
9
Natalizumab treatment of multiple sclerosis - a Danish nationwide study with 13 years of follow-up
enthalten in:
Multiple sclerosis and related disorders
| 2023
von
Buron, M.
|
Christensen, J.
|
Pontieri, L.
| +7
Wird geladen...
10
Clinical and fringe benefits of rituximab in multiple sclerosis treatment in a poor resource setting : Case series and cost analysis
enthalten in:
Multiple sclerosis and related disorders
| 2023
von
Aungsumart, S.
|
Apiwattanakul, M.
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[30]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Multiple sclerosis and related disorders
Medienart
298
Aufsätze
298
E-Artikel
298
E-Ressourcen
Zeitschriftentitel
Multiple sclerosis and related disorders
Thema
298
Immunologic Factors
252
Journal Article
180
Multiple sclerosis
81
Case Reports
74
Natalizumab
47
Rituximab
45
4F4X42SYQ6
43
Antibodies, Monoclonal, Humanized
37
Review
35
Alemtuzumab
33
3A189DH42V
33
ocrelizumab
32
A10SJL62JY
31
Observational Study
29
Fingolimod Hydrochloride
29
G926EC510T
26
Multicenter Study
26
Ocrelizumab
25
Interferon-beta
24
77238-31-4
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
139
2020-
159
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
298
Englisch
Haven't found what you're looking for?
Wird geladen...